Within our PD-L1 expression evaluation pipeline, precise tumor region localization is followed by quantification of PD-L1+ tumor cells, PD-L1− tumor cells, and PD-L1+ immune cells within tumor-associated regions. Here, CD274 is linked to neoplasm.